Vigonvita Life Sciences Co., Ltd. (HKG:2630)
Hong Kong · Delayed Price · Currency is HKD 57.90
+0.10 (0.17%)
Jun 23, 2026, 2:24 PM HKT
Vigonvita Life Sciences Market Cap
Vigonvita Life Sciences has a market cap or net worth of 9.69 billion as of June 22, 2026.
Market Cap
9.69B
Enterprise Value
9.82B
Revenue
113.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
57.90
Market Cap Chart
Since November 6, 2025, Vigonvita Life Sciences's market cap has decreased from 13.74B to 9.69B, a decrease of -29.51%. That is a compound annual growth rate of -42.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 9.69B | -29.38% |
| Dec 31, 2025 | 13.72B | -0.18% |
| Nov 6, 2025 | 13.74B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 235.39B |
| Hansoh Pharmaceutical Group Company | 179.34B |
| Innovent Biologics | 132.37B |
| WuXi Biologics | 127.07B |
| Xunfei Healthcare Technology | 10.29B |
| IMPACT Therapeutics | 10.22B |
| CARsgen Therapeutics Holdings | 10.00B |
| CanSino Biologics | 9.60B |